Pharmacokinetics and Safety of Intravenous Ferric Pyrophosphate Citrate: Equivalence to Administration via Dialysate

Ferric pyrophosphate citrate (FPC) is indicated to maintain hemoglobin in patients with stage 5 hemodialysis‐dependent chronic kidney disease on chronic hemodialysis by addition to the dialysate. An intravenous (IV) FPC presentation containing 6.75 mg of iron in 4.5 mL was developed. The objective w...

Descripción completa

Detalles Bibliográficos
Autores principales: Marbury, Thomas, van Heuveln, Fred, van der Horst, Eric, Pratt, Raymond D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Pharmacokinetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303319/
https://www.ncbi.nlm.nih.gov/pubmed/34743348
http://dx.doi.org/10.1002/jcph.1997

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303319/
https://www.ncbi.nlm.nih.gov/pubmed/34743348
http://dx.doi.org/10.1002/jcph.1997

Ejemplares similares